FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.13  |  FHIR Version n/a  User: [n/a]

38112003: 1 (qualifier value)

    Status: retired, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jan 2023. Module: SNOMED CT core

    Descriptions:

    Id Description Lang Type Status Case? Module
    64719019 One en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442104013 1 (qualifier value) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
    3442105014 1 en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core

    0 descendants.

    Expanded Value Set

    Outbound Relationships Type Target Active Characteristic Refinability Group Values
    1 Is a General adjectival modifier false Inferred relationship Some
    1 Is a Number false Inferred relationship Some
    Inbound Relationships Type Active Source Characteristic Refinability Group
    Dupilumab 150 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely dupilumab 175.439 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Secukinumab 150 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Secukinumab 150 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Fenfluramine 2.2 mg/mL oral solution Count of base of active ingredient False 1 Inferred relationship Some
    Fenfluramine 2.2 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sofosbuvir 200 milligram and velpatasvir 50 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely sofosbuvir 400 milligram and velpatasvir 100 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely bedaquiline (as bedaquiline fumarate) 20 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet Count of base of active ingredient False 1 Inferred relationship Some
    Bedaquiline (as bedaquiline fumarate) 100 mg oral tablet Has presentation strength denominator value False 1 Inferred relationship Some 1
    Monomethyl fumarate 95 mg oral capsule Count of base of active ingredient False 1 Inferred relationship Some
    Monomethyl fumarate 95 mg oral capsule Has presentation strength denominator value False 1 Inferred relationship Some 1
    Monomethyl fumarate only product Count of base of active ingredient False 1 Inferred relationship Some
    Monomethyl fumarate only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 1
    Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 2
    Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 3
    Calcium oxybate 500 mg/mL and magnesium oxybate 500 mg/mL and potassium oxybate 500 mg/mL and sodium oxybate 500 mg/mL oral solution Has concentration strength denominator value False 1 Inferred relationship Some 4
    Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely elagolix sodium 300 milligram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength numerator value False 1 Inferred relationship Some 2
    Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely elagolix sodium 300 milligram and estradiol 1 milligram and norethisterone 500 microgram/1 each conventional release oral capsule (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 3
    Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely Clostridium histolyticum collagenase 900 microgram/1 vial lyophilized powder for conventional release solution for injection (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Vaccine product containing only Haemophilus influenzae type b capsular polysaccharide polyribosylribitol phosphate conjugated to Clostridium tetani toxoid protein (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Vaccine product containing only Streptococcus pneumoniae Danish serotype 4, 6B, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Minocycline only product in cutaneous dose form Count of base of active ingredient False 1 Inferred relationship Some
    Fenfluramine only product in oral dose form Count of base of active ingredient False 1 Inferred relationship Some
    Remdesivir 5 mg/mL solution for injection Count of base of active ingredient False 1 Inferred relationship Some
    Remdesivir 5 mg/mL solution for injection Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing only Glycine max oil refined in parenteral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only Glycine max oil refined (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely ethanol 0.7 milliliter/1 milliliter conventional release cutaneous solution (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely agomelatine (as agomelatine citric acid) 25 milligram/1 each conventional release oral tablet (clinical drug) Has presentation strength denominator value False 1 Inferred relationship Some 1
    Carbon (13-C) urea only product Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only carbon (13-C) urea in oral dose form (medicinal product form) Count of base of active ingredient False 1 Inferred relationship Some
    Streptococcus pneumoniae Danish serotype 1, 2, 3, 4, 5, 6B, 7F, 8, 9N, 9V, 10A, 11A, 12F, 14, 15B, 17F, 18C, 19A, 19F, 20, 22F, 23F, and 33F capsular polysaccharide antigens only vaccine product Count of base of active ingredient False 1 Inferred relationship Some
    Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 3, 4, 5, 6A, 6B, 7F, 9V, 14, 18C, 19A, 19F, and 23F capsular polysaccharide antigens (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Vaccine product containing only Streptococcus pneumoniae Danish serotype 1, 4, 5, 6B, 7F, 9V, 14, 18C, 19F, and 23F capsular polysaccharide antigens conjugated (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product Count of active ingredient False 1 Inferred relationship Some
    Inactivated whole Influenza A virus subtype H5N1 antigen only vaccine product Count of base of active ingredient False 1 Inferred relationship Some
    SARS-CoV-2 antigen vaccine Count of base of active ingredient False 1 Inferred relationship Some
    Product containing only bamlanivimab (medicinal product) Count of base of active ingredient False 1 Inferred relationship Some
    Bamlanivimab only product in parenteral dose form Count of base of active ingredient False 1 Inferred relationship Some
    SARS-CoV-2 mRNA vaccine Count of base of active ingredient False 1 Inferred relationship Some
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 10 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 1
    Product containing precisely cyclizine tartrate 50 milligram/1 milliliter and morphine tartrate 15 milligram/1 milliliter conventional release solution for injection (clinical drug) Has concentration strength denominator value False 1 Inferred relationship Some 2

    Start Previous Page 215 of 215

    Reference Sets

    Concept inactivation indicator reference set

    Back to Start